Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Febrile Neutropenia
Interventions: DRUG: EC-18
Sponsor: Enzychem Lifesciences Corporation